Cencora, Inc. (COR) Stock Forecast
Data as of Jul 31, 2026Healthcare · Current price $312.38 (+0.08%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 22, 2026 | Brian Tanquilut | Jefferies | $440.00 | +40.9% |
| Jan 13, 2026 | Eric Coldwell | Robert W. Baird | $415.00 | +32.9% |
| Nov 7, 2025 | Kevin Caliendo | UBS | $415.00 | +32.9% |
| Oct 30, 2025 | Steven Valiquette | Mizuho Securities | $340.00 | +8.8% |
| Oct 16, 2025 | Steven Valiquette | Mizuho Securities | $334.00 | +6.9% |
| Aug 13, 2025 | Stephen Baxter | Wells Fargo | $354.00 | +13.3% |
| Jul 16, 2025 | Erin Wright | Morgan Stanley | $330.00 | +5.6% |
| Apr 15, 2025 | Erin Wright | Morgan Stanley | $288.00 | -7.8% |
| Sep 18, 2024 | Daniel Grosslight | Citigroup | $284.00 | -9.1% |
| Sep 18, 2024 | Allen Lutz | Bank of America Securities | $245.00 | -21.6% |
| Sep 6, 2024 | David Rodgers | Robert W. Baird | $283.00 | -9.4% |
| Aug 1, 2024 | David Rodgers | Robert W. Baird | $287.00 | -8.1% |
| May 29, 2024 | David Rodgers | Robert W. Baird | $280.00 | -10.4% |
| Apr 5, 2024 | David Rodgers | Robert W. Baird | $275.00 | -12.0% |
| Apr 4, 2024 | David Toung | Argus Research | $270.00 | -13.6% |
| May 3, 2023 | Ann Hynes | Mizuho Securities | $174.00 | -44.3% |
| Jul 19, 2022 | Elizabeth Anderson | Evercore ISI | $150.00 | -52.0% |
| Jun 23, 2022 | Kevin Caliendo | UBS | $174.00 | -44.3% |
| Jun 10, 2022 | George Hill | Deutsche Bank | $178.00 | -43.0% |
| Jun 2, 2022 | Elizabeth Anderson | Evercore ISI | $165.00 | -47.2% |
Top Analysts Covering COR
COR vs Sector & Market
| Metric | COR | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.08 | 2.25 | 2.42 |
| Analyst Count | 12 | 8 | 19 |
| Target Upside | +16.1% | +16366.1% | +18.0% |
| P/E Ratio | 37.55 | 2.98 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $339.32B | $345.49B | $348.28B | 10 |
| 2027-09-30 | $356.97B | $367.65B | $371.84B | 10 |
| 2027-12-31 | $95.19B | $97.14B | $98.17B | 3 |
| 2028-03-31 | $92.82B | $94.73B | $95.73B | 2 |
| 2028-06-30 | $99.11B | $101.14B | $102.22B | 5 |
| 2028-09-30 | $103.51B | $105.63B | $106.75B | 4 |
| 2028-12-31 | $109.39B | $111.64B | $112.82B | 4 |
| 2029-03-31 | $102.04B | $104.13B | $105.24B | 5 |
| 2029-06-30 | $107.80B | $110.01B | $111.18B | 3 |
| 2029-09-30 | $115.71B | $118.09B | $119.34B | 3 |
| 2030-09-30 | $467.30B | $477.84B | $482.74B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $17.50 | $17.62 | $17.69 | 8 |
| 2027-09-30 | $19.15 | $19.52 | $19.99 | 8 |
| 2027-12-31 | $4.82 | $4.95 | $5.02 | 6 |
| 2028-03-31 | $5.81 | $5.97 | $6.05 | 4 |
| 2028-06-30 | $5.30 | $5.45 | $5.52 | 6 |
| 2028-09-30 | $5.32 | $5.46 | $5.54 | 4 |
| 2028-12-31 | $5.27 | $5.41 | $5.48 | 7 |
| 2029-03-31 | $6.35 | $6.52 | $6.61 | 3 |
| 2029-06-30 | $5.55 | $5.70 | $5.78 | 5 |
| 2029-09-30 | $5.46 | $5.61 | $5.69 | 3 |
| 2030-09-30 | $27.04 | $27.84 | $28.21 | 1 |
Frequently Asked Questions
What is the analyst consensus for COR?
The consensus among 12 analysts covering Cencora, Inc. (COR) is Buy with an average price target of $378.57.
What is the highest price target for COR?
The highest price target for COR is $440.00, set by Brian Tanquilut at Jefferies on 2026-01-22.
What is the lowest price target for COR?
The lowest price target for COR is $142.00, set by Ricky Goldwasser at Morgan Stanley on 2021-12-17.
How many analysts cover COR?
12 analysts have issued ratings for Cencora, Inc. in the past 12 months.
Is COR a buy or sell right now?
Based on 12 analyst ratings, COR has a consensus rating of Buy (2.08/5) with a +16.1% upside to the consensus target of $378.57.
What are the earnings estimates for COR?
Analysts estimate COR will report EPS of $17.62 for the period ending 2026-09-30, with revenue estimated at $345.49B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.